Cite

HARVARD Citation

    Gerdts, E. et al. (n.d.). Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record